stockportfolio.pro
Mobia Medical, Inc. (MOBI)
Healthcare · Medical Devices · NasdaqGS
Mobia Medical, Inc. revenue & earnings — last 2 fiscal years
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $15.64M | $32.04M |
| Gross profit | $12.45M | $25.98M |
| Net income | $-24.60M | $-46.50M |
| Net margin | -157.3% | -145.1% |
Source: Mobia Medical, Inc. SEC filings (10-K).
Explore 2 years of Mobia Medical, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track MOBI in your portfolio →
Mobia Medical, Inc. financial history by metric
About Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Mobia Medical, Inc. — frequently asked questions
What is Mobia Medical, Inc.'s revenue?
Mobia Medical, Inc. (MOBI) reported revenue of $32.04M for fiscal year 2025, up 104.8% from the prior year, according to its SEC filings.
Is Mobia Medical, Inc. profitable?
No — MOBI reported a net loss of $-46.50M in fiscal 2025.
What is MOBI's P/E ratio?
Mobia Medical, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How much debt does Mobia Medical, Inc. have?
As of fiscal year 2025, MOBI carried roughly $7.13M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Mobia Medical, Inc.'s gross margin?
MOBI's gross margin was 81.1% in fiscal 2025 — gross profit of $25.98M on revenue of $32.04M.
What is Mobia Medical, Inc.'s market cap?
Mobia Medical, Inc. (MOBI) has a market capitalization of about $418.44M, based on the latest data in our nightly-refreshed cache.
When does Mobia Medical, Inc.'s fiscal year end?
MOBI's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Mobia Medical, Inc.'s official SEC filings (10-K and 10-Q), covering 2 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.